What does The Akkermansia Company do?

The Akkermansia Company is a research organisation in Mont-Saint-Guibert. Public Limited, started on 11 October 2016, 1 establishment.

What is the address of The Akkermansia Company?

The registered office of The Akkermansia Company is located at Rue Granbonpré 11, 1435 Mont-Saint-Guibert.

Is The Akkermansia Company still active?

Yes. According to the CBE (29 October 2026) The Akkermansia Company is active, legal situation “Normale toestand”, started on 11 October 2016.

Is The Akkermansia Company registered on Peppol?

Yes, The Akkermansia Company is registered on the Peppol network with ID 0208:0664529083.

What is the enterprise number of The Akkermansia Company?

The enterprise number of The Akkermansia Company is BE0664529083.

When was The Akkermansia Company founded?

The Akkermansia Company was founded on 11 October 2016.

Who are the directors of The Akkermansia Company?

According to the 2025 annual accounts, the directors of The Akkermansia Company are: Seventure Partners, Emre Kasikci, Alogis AB, Innovation Industries Fund Coöperatief UA, Vives Partners, Alopekos Holding BV, Sparaxis SA, John Agwunobi.

Is The Akkermansia Company a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 October 2016; 5 annual accounts filed, latest fiscal year 2025; 10 directors known from the annual account.

How much profit did The Akkermansia Company make in 2025?

The Akkermansia Company recorded a loss after taxes of € 9,395,982 in financial year 2025.

What is the revenue of The Akkermansia Company?

As a small company, The Akkermansia Company is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -3,584,375.

How much does an employee at The Akkermansia Company earn?

The average wage cost per full-time employee at The Akkermansia Company was € 96,400 in 2025: staff costs of € 289,136 for 3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does The Akkermansia Company have?

According to the 2025 annual accounts, The Akkermansia Company has 3 full-time equivalents (FTE).

The Akkermansia Company (Public Limited)

Dossier The Akkermansia Company, printed on 29 October 2026 from databakkes.be/en/0664529083/the-akkermansia-company. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 1 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2024 and 2025.
Shrinking team NBB

FTE fell two years in a row, from 4.1 to 3.
Busy address KBO

20 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

The Akkermansia Company from Mont-Saint-Guibert, company number BE0664529083, closed financial year 2025 with a result of € -9.4 million after tax. For that financial year The Akkermansia Company recorded a gross margin of € -3.6 million and equity of € -3.4 million. Compared with financial year 2024, the result moved from € -3.6 million to € -9.4 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 5, 2026.

What it is worth Caution

€ -3.4 million

▼ € 10.1 million vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -9.4 million

▼ 158 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 2.3 million

▼ 65% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -31.6 million.

People and assets in 2025

Full-time equivalents

▼ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 289,136

▲ 7% vs 2024

€ 96,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 20,575

▼ 20% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 2.9 million

▼ 65% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 4.9 million

▲ 83% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 58,318

▲ 14% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -3,253,066 Gross margin 2022: € -3,253,066 First fiscal year in the series	€ -3,959,687 Gross margin 2023: € -3,959,687 ▼ € 706,621 vs 2022 (€ -3,253,066) Unfavourable step	€ -1,485,173 Gross margin 2024: € -1,485,173 ▲ € 2.5 million vs 2023 (€ -3,959,687) Favourable step	€ -3,584,375 Gross margin 2025: € -3,584,375 ▼ € 2.1 million vs 2024 (€ -1,485,173) Unfavourable step	▼ € 2.1 million
Profit after taxes	€ -4,234,402 Profit after taxes 2022: € -4,234,402 First fiscal year in the series	€ -5,024,764 Profit after taxes 2023: € -5,024,764 ▼ € 790,362 vs 2022 (€ -4,234,402) Unfavourable step	€ -3,645,948 Profit after taxes 2024: € -3,645,948 ▲ € 1.4 million vs 2023 (€ -5,024,764) Favourable step	€ -9,395,982 Profit after taxes 2025: € -9,395,982 ▼ € 5.8 million vs 2024 (€ -3,645,948) Unfavourable step	▼ € 5.8 million
Equity	€ 6,635,790 Equity 2022: € 6,635,790 First fiscal year in the series	€ 10,412,446 Equity 2023: € 10,412,446 ▲ 57% vs 2022 (€ 6,635,790) Favourable step	€ 6,655,735 Equity 2024: € 6,655,735 ▼ 36% vs 2023 (€ 10,412,446) Unfavourable step	€ -3,444,264 Equity 2025: € -3,444,264 ▼ € 10.1 million vs 2024 (€ 6,655,735) Unfavourable step	▼ € 10.1 million
Total debts	€ 2,636,534 Total debts 2022: € 2,636,534 First fiscal year in the series	€ 3,016,797 Total debts 2023: € 3,016,797 ▲ 14% vs 2022 (€ 2,636,534) Unfavourable step	€ 11,981,115 Total debts 2024: € 11,981,115 ▲ 297% vs 2023 (€ 3,016,797) Unfavourable step	€ 20,296,181 Total debts 2025: € 20,296,181 ▲ 69% vs 2024 (€ 11,981,115) Unfavourable step	▲ 69%
Cash	€ 478,228 Cash 2022: € 478,228 First fiscal year in the series	€ 4,102,140 Cash 2023: € 4,102,140 ▲ € 3.6 million vs 2022 (€ 478,228) Favourable step	€ 6,608,881 Cash 2024: € 6,608,881 ▲ 61% vs 2023 (€ 4,102,140) Favourable step	€ 2,299,647 Cash 2025: € 2,299,647 ▼ 65% vs 2024 (€ 6,608,881) Unfavourable step	▼ 65%
Retained profit	€ -13,542,637 Retained profit 2022: € -13,542,637 First fiscal year in the series	€ -18,567,400 Retained profit 2023: € -18,567,400 ▼ € 5 million vs 2022 (€ -13,542,637) Unfavourable step	€ -22,213,347 Retained profit 2024: € -22,213,347 ▼ € 3.6 million vs 2023 (€ -18,567,400) Unfavourable step	€ -31,609,329 Retained profit 2025: € -31,609,329 ▼ € 9.4 million vs 2024 (€ -22,213,347) Unfavourable step	▼ € 9.4 million
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 56,544 Bank debt 2023: € 56,544 Unchanged (€ 0) Unfavourable step	€ 8,134,077 Bank debt 2024: € 8,134,077 ▲ € 8.1 million vs 2023 (€ 56,544) Unfavourable step	€ 2,882,412 Bank debt 2025: € 2,882,412 ▼ 65% vs 2024 (€ 8,134,077) Favourable step	▼ 65%
Balance sheet total	€ 9,272,324 Balance sheet total 2022: € 9,272,324 First fiscal year in the series	€ 13,429,243 Balance sheet total 2023: € 13,429,243 ▲ 45% vs 2022 (€ 9,272,324) Unchanged	€ 18,636,850 Balance sheet total 2024: € 18,636,850 ▲ 39% vs 2023 (€ 13,429,243) Unchanged	€ 16,851,916 Balance sheet total 2025: € 16,851,916 ▼ 10% vs 2024 (€ 18,636,850) Unchanged	▼ 10%
Employees (FTE)	4.8 Employees (FTE) 2022: 4.8 First fiscal year in the series	4.1 Employees (FTE) 2023: 4.1 ▼ 0.7 vs 2022 (4.8) Unchanged	3.5 Employees (FTE) 2024: 3.5 ▼ 0.6 vs 2023 (4.1) Unchanged	3 Employees (FTE) 2025: 3 ▼ 0.5 vs 2024 (3.5) Unchanged	▼ 0.5

Key figures of The Akkermansia Company, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to The Akkermansia Company?

What happened at The Akkermansia Company in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2031 Compagnie Gervais Danone stepped down as director. NBB
2031 Emre Kasikci stepped down as director. NBB
Oct 5, 2026 New annual accounts for financial year 2025: loss of € 9.4 million. filed late Source: NBB ↗
2025 Seventure Partners stepped down as director. NBB
2025 Emre Kasikci became a director. NBB
2025 Alogis AB stepped down as director. NBB
2025 Innovation Industries Fund Coöperatief UA stepped down as director. NBB
2025 Vives Partners stepped down as director. NBB

In short

From € 4.2 million loss in 2022 to € 9.4 million loss in 2025.

Paid € 101,974 in corporate taxes since 2022.

Original PDFs at the National Bank ↗

Management

Wallonie Entreprendre 13.3%

VIVES II - Louvain Technology Fund 12%

SOPARTEC 5.7%

SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON 2%

The stake of Wallonie Entreprendre, VIVES II - Louvain Technology Fund, SOPARTEC, SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

The Akkermansia Company

The shares are held by Wallonie Entreprendre (13.3%), VIVES II - Louvain Technology Fund (12%), SOPARTEC (5.7%) and SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON (2%).

Directors

According to the 2025 annual accounts

Seventure Partners

Director · represented by Nora Frey

since 2023 · until 2025

Emre Kasikci

Director

since 2025 · until 2031

Alogis AB

Chairman of the board · represented by Erici Ola

since 2023 · until 2025

Innovation Industries Fund Coöperatief UA

Director · represented by Caaj Grebe

since 2023 · until 2025

Vives Partners

Director · represented by Philippe Durieux

Also active at: NOVADIP BIOSCIENCES, TESSARES, AXINESIS, Sunrise, ViroVet, VOCSens, Vives Inter-University Fund, NeGIO Therapeutics +4 more

since 2024 · until 2025

Alopekos Holding BV

Director · represented by Willem de Vos

since 2023 · until 2025

Sparaxis SA

Director · represented by Sophie Sauvage

Also active at: C.P. Bourg, A.M.B., Jean Goldschmidt International, Ateliers Pierre Cerfontaine, Floridienne, Fonderies J. Marichal Ketin et Cie, JUNGLING, MEBF +224 more

since 2023 · until 2025

John Agwunobi

Director

since 2023 · until 2025

Compagnie Gervais Danone

Représentant permanent · represented by Antoine Guttinger

since 2025 · until 2031

Nothern Lights Southern Cross Belgium SRL

Managing director · represented by Michael Oredsson

since 2023 · until 2025

Shareholders

Wallonie Entreprendre

13.3%

VIVES II - Louvain Technology Fund

12%

SOPARTEC

5.7%

SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Granbonpré 11

1435 Mont-Saint-Guibert

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.

All companies at this address →

DE SMET AGRO

€ 8.7 million revenue · 2025

DE SMET S.A. - ENGINEERS & CONTRACTORS same network

€ 31.8 million revenue · 2025

CEDRIC CLAERHOUDT

€ 937,969 gross margin · 2024

Tools4Patient same network

€ -431,027 gross margin · 2025

NOVADIP BIOSCIENCES same network

€ 1.6 million gross margin · 2025

+15 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0664.529.083
VAT number: BE 0664.529.083
Registered office: Rue Granbonpré 11, 1435 Mont-Saint-Guibert
Names & denominations: The Akkermansia Company
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 11 October 2016
Peppol: Active · Active since 2 Feb 2026
Activities · NACE: Speur- en ontwikkelingswerk op biotechnologisch gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

The Akkermansia Company

Warning lights

Financials

What happened to The Akkermansia Company?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions